A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION
Digestive and Liver Disease
; 54:S93-S93, 2022.
Article
in English
| PMC | ID: covidwho-1821546
Full text:
Available
Collection:
Databases of international organizations
Database:
PMC
Language:
English
Journal:
Digestive and Liver Disease
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS